Related Experiment Videos
Triglyceride-glucose index is independently associated with left ventricular outflow tract obstruction in
Tolga Kunak1, Özkan Kayhan2, Ayşegül Ülgen Kunak3
1Department of Cardiology, Akdeniz University Faculty of Medicine, Antalya, Türkiye.
Insights
The triglyceride-glucose (TyG) index, a marker for insulin resistance, is independently associated with left ventricular outflow tract (LVOT) obstruction in hypertrophic cardiomyopathy (HCM) patients. Higher TyG index values correlate with obstructive HCM, suggesting a link between metabolic health and disease severity.
Area of Science:
- Cardiology
- Metabolic Syndrome
- Cardiovascular Research
Background:
- Insulin resistance and metabolic dysregulation contribute to myocardial remodeling in hypertrophic cardiomyopathy (HCM).
- The triglyceride-glucose (TyG) index is a surrogate marker for insulin resistance.
- The association between the TyG index and left ventricular outflow tract (LVOT) obstruction in HCM is not well understood.
Purpose of the Study:
- To investigate the association between the TyG index and LVOT obstruction in adult HCM patients.
- To determine if the TyG index can predict or correlate with LVOT obstruction severity.
Main Methods:
- Retrospective observational study of 124 adult HCM patients.
- Calculation of TyG index from fasting triglyceride and glucose levels.
- Multivariable logistic regression and ROC curve analysis to assess association and discriminatory performance.
Main Results:
- Patients with obstructive HCM had significantly higher TyG index values (9.07 ± 0.25) than non-obstructive HCM patients (8.76 ± 0.21).
- The TyG index showed an independent association with LVOT obstruction (OR 1.84 per 0.1-unit increase).
- TyG index demonstrated moderate correlations with resting (r=0.519) and provoked (r=0.557) LVOT gradients, with good discriminatory performance (AUC: 0.826).
Conclusions:
- The TyG index is independently associated with LVOT obstruction in HCM patients.
- Higher TyG index values are linked to the obstructive phenotype in HCM.
- The TyG index may offer complementary clinical insights into metabolic status and disease manifestation in HCM, warranting further investigation.
Abstract:
Insulin resistance and metabolic dysregulation are increasingly recognized as contributors to myocardial remodeling and phenotypic heterogeneity in hypertrophic cardiomyopathy (HCM). While the triglyceride-glucose (TyG) index offers a simple surrogate marker of insulin resistance, its relationship with left ventricular outflow tract (LVOT) obstruction in HCM patients remains underexplored. This study aimed to investigate the association between the TyG index and LVOT obstruction in a retrospective observational cohort of 124 adult HCM patients. LVOT obstruction was defined as a resting or provoked gradient of ≥30 mmHg. Clinical, laboratory, and echocardiographic data were systematically evaluated. The TyG index was computed from fasting triglyceride and glucose levels. Multivariable logistic regression analysis, with the TyG index scaled per 0.1-unit increment, was used to assess independent associations. Receiver operating characteristic (ROC) curve analysis determined discriminatory performance. Patients with obstructive HCM exhibited significantly higher TyG index values compared to those without obstruction (9.07 ± 0.25 vs. 8.76 ± 0.21, p<0.001). The TyG index maintained an independent association with LVOT obstruction after adjusting for relevant clinical and echocardiographic covariates (per 0.1-unit increase: OR 1.84, 95% CI 1.40-2.42, p<0.001). Furthermore, the TyG index demonstrated moderate correlations with both resting (r=0.519, p<0.001) and provoked (r=0.557, p<001) LVOT gradients. ROC analysis indicated good discriminatory performance (AUC: 0.826, 95% CI: 0.752-0.901), with a cut-off value of 8.75 yielding 87.9% sensitivity and 47.0% specificity. In conclusion, the TyG index was independently associated with LVOT obstruction in HCM patients, with higher values observed in those with the obstructive phenotype. This suggests a potential link between metabolic status and disease manifestation in HCM. Given its cost-effectiveness and accessibility, the TyG index may offer valuable complementary clinical insights. However, this association requires cautious interpretation, and prospective studies are essential to establish its clinical and prognostic utility.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy